USO 22095
A Phase 1/2, Open-Label, Dose-Escalation, Dose-Expansion Study ng DSP-5336 sa mga Nasa hustong gulang na Pasyente na may Acute Leukemia at Iba Pang Napiling Hematologic Malignancies, mayroon at walang Mixed Lineage Leukemia (MLL) rearrangement o Nucleophosmin 1 (NPM1) Mutation (DSP-5336-101)
Mga Uri ng Sakit: Leukemia at Lymphoma Research
Available sa: